Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of Arbutus Biopharma's Imdusiran Sodium?
Imdusiran Sodium is an antisense rnai oligonucleotide commercialized by Arbutus Biopharma, with a leading Phase II program in Hepatitis B....